Order Article Reprints

Khirallah SM, Ramadan HMM, Aladl HAA, Ayaz NO, Kurdi LAF, Jaremko M, Alshawwa SZ, Saied EM. Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities. Pharmaceuticals. 2022; 15(12):1576. https://doi.org/10.3390/ph15121576

Khirallah, Salma M., Heba M. M. Ramadan, Hossam Aladl Aladl Aladl, Najla O. Ayaz, Lina A. F. Kurdi, Mariusz Jaremko, Samar Zuhair Alshawwa, and Essa M. Saied. 2022. "Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities" Pharmaceuticals 15, no. 12: 1576. https://doi.org/10.3390/ph15121576

Khirallah, S. M., Ramadan, H. M. M., Aladl, H. A. A., Ayaz, N. O., Kurdi, L. A. F., Jaremko, M., Alshawwa, S. Z., & Saied, E. M. (2022). Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities. Pharmaceuticals, 15(12), 1576. https://doi.org/10.3390/ph15121576